Lab
Clinical Diagnostic Laboratories, LLC
Clinical Diagnostic Laboratories, LLC was paid $278K by Medicaid between Jun 2019 and Dec 2024, across 27 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 49% of everything it billed.
33Billing provider infoCLINICAL DIAGNOSTIC LABORATORIES, LLC
ASHBURN, VA 20147
ASHBURN, VA 20147
33aNPI1881101475assigned 01/04/2018
33bProvider typeClinical Medical Laboratory
28Total paid$278K
24GClaims25,013
24DCodes billed27
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Virginia
Rank by total paid#28 of 78
Median peer was paid$37K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 127 | $17.26 | |
| 2020 | 4,257 | $71K | |
| 2021 | 8,449 | $91K | |
| 2022 | 6,065 | $55K | |
| 2023 | 4,169 | $40K | |
| 2024incomplete | 1,946 | $20K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 49% | 6,188 | 2,502 | $136K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 13% | 6,046 | 2,415 | $37K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 10% | 4,441 | 1,564 | $28K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 8.4% | 1,300 | 743 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.0% | 1,050 | 672 | $19K |
| 86413 | 5.8% | 736 | 496 | $16K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 2.3% | 449 | 321 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 585 | 387 | $4K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 1.3% | 823 | 569 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 130 | 69 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 561 | 333 | $307.24 |
| 80053 | Comprehensive metabolic panel | <1% | 220 | 147 | $242.88 |
15 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 36 | $94.17 |
| 86769 | <1% | 454 | $93.53 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 495 | $88.85 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 29 | $70.18 |
| 86328 | <1% | 451 | $55.14 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 53 | $43.14 |
| 80061 | Lipid panel | <1% | 49 | $26.78 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 34 | $9.71 |
| 86592 | <1% | 30 | $8.36 | |
| 99000 | <1% | 13 | $3.68 | |
| 86480 | <1% | 37 | $3.65 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 22 | $2.07 |
| A4770 | Blood collection tube, vacuum, for dialysis, per 50 | <1% | 204 | $0.60 |
| 99072 | 0% | 561 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAWADELKARIEM, IBTIHAJ (CEO/TECHNICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Iym Services LLC | Sterling, VA | $204.82 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.